The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries

Kamlesh Khunti, S. Caputo, T. Damci, G. J. Dzida, Q. Ji, M. Kaiser, E. Karnieli, A. Liebl, R. J. Ligthelm, A. Nazeri, D. Orozco-Beltran, C. Pan, S. A. Ross, A. L. Svendsen, J. Vora, J. F. Yale, L. F. Meneghini, A. Maran, L. Raimundo, S. ArtolaS. Imamoglu